- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully…
Two PROTAC synergy using two E3 ligases for achieving levels of degradation of KRAS G12D not achieved with single PROTACs,…
AI-powered, on-demand access to clinical content enhances HCP interactions and drives measurable commercial impact for pharmaceutical companies. SAN DIEGO, April…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…
ALAMEDA, Calif., April 23, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results…
Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) a leader in the…
Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) a leader in the…
CLEVELAND, April 23, 2025 /PRNewswire/ -- Coologics Inc., a clinical-stage medical device company, today announced the successful closing of their…
CLEVELAND, April 23, 2025 /PRNewswire/ -- Coologics Inc., a clinical-stage medical device company, today announced the successful closing of their…
A Trusted Forum Where Real People Share, Learn, and Navigate The Prescription Drug Journey; Starting With GLP1s NEW YORK, April…